Concepedia

Author

Nelly Robillard

InsermORCID

Also Known As

Genevie Ve, N Robillard, N. Robillard, NELLY ROBILLARD, Nelly Robillard, Robillard N., Robillard Nelly

149

Publications

6.2K

Citations

42

H-Index

78

Concepts

All Affiliations

InsermCentre Hospitalier Universitaire de NantesNantes UniversitéHôtel-Dieu de ParisHôpital Saint-Louis
NR

About

Nelly Robillard is an author at Inserm specializing in medicine, pathology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

25

34

2.5K

2

Health Sciences

8

8

366

3

Engineering

1

1

33

4

Allergy

1

1

62

5

Blood Transplantation

1

1

14

Nelly Robillard

×

71

Publications

5.6K

Citations

40

H-Index

YearCitations

Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma

Aurore Perrot, Valérie Lauwers‐Cancès, Jill Corre,

Blood

2018

408

Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival

Soraya Wuillème‐Toumi, Nelly Robillard, P Gomez,

Leukemia

2005

336

Randomized Controlled Trial of a Monoclonal Antibody against the Interleukin-2 Receptor (33B3.1) as Compared with Rabbit Antithymocyte Globulin for Prophylaxis against Rejection of Renal Allografts

Jean-Paul Soulillou, Diego Cantarovich, Brigitte Le Mauff,

New England Journal of Medicine

1990

274

Contrasting CD25hiCD4+T Cells/FOXP3 Patterns in Chronic Rejection and Operational Drug-Free Tolerance

St phanie Louis, Cécile Braudeau, Magali Giral,

Transplantation

2006

271

Front-Line Transplantation Program With Lenalidomide, Bortezomib, and Dexamethasone Combination As Induction and Consolidation Followed by Lenalidomide Maintenance in Patients With Multiple Myeloma: A Phase II Study by the Intergroupe Francophone du Myélome

Murielle Roussel, Valérie Lauwers‐Cancès, Nelly Robillard,

Journal of Clinical Oncology

2014

263

Noxa Up-regulation and Mcl-1 Cleavage Are Associated to Apoptosis Induction by Bortezomib in Multiple Myeloma

Patricia Gomez‐Bougie, Soraya Wuillème‐Toumi, Emmanuelle Ménoret,

Cancer Research

2007

237

The phenotype of normal, reactive and malignant plasma cells. Identification of "many and multiple myelomas" and of new targets for myeloma therapy.

Régis Bataille, Gaëtan Jégo, Nelly Robillard,

PubMed

2006

225

Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells

Catherine Pellat‐Deceunynck, Régis Bataille, Nelly Robillard,

Blood

1994

211

Zoledronate Is a Potent Inhibitor of Myeloma Cell Growth and Secretion of IL-6 and MMP-1 by the Tumoral Environment

Sophie Derenne, Martine Amiot, Sophie Barillé‐Nion,

Journal of Bone and Mineral Research

1999

197

The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma

Catherine Pellat‐Deceunynck, Gaëtan Jégo, Denis Puthier,

Leukemia

1998

193

Page 1